SCHEMBL984903

SCHEMBL984903

CCCCCCCCCc1ccccc1N

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.58
TLR8 Q9NR97 3/20 0.49
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
BID P55957 3/20 0.45
MCL1 Q07820 3/20 0.45
BCL2L1 Q07817 2/20 0.45
BAK1 Q16611 2/20 0.45
KAT8 Q9H7Z6 2/20 0.45
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
EP300 Q09472 1/20 0.45
KAT2A Q92830 1/20 0.45
KAT2B Q92831 1/20 0.45
KAT5 Q92993 1/20 0.45
SAE1 Q9UBE0 1/20 0.45
THRA P10827 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL634069 1.00 LIPG (0.58) LIPGTLR8NR1H2NR1H3CYP1A2
SCHEMBL4069404 1.00 LIPG (0.58) LIPGTLR8NR1H2NR1H3CYP1A2
SCHEMBL112711 1.00 LIPG (0.58) LIPGTLR8NR1H2NR1H3CYP1A2
SCHEMBL2230507 1.00 LIPG (0.58) LIPGTLR8NR1H2NR1H3CYP1A2
SCHEMBL634079 1.00 LIPG (0.58) LIPGTLR8NR1H2NR1H3CYP1A2
SCHEMBL4431698 1.00 LIPG (0.58) LIPGTLR8NR1H2NR1H3CYP1A2
SCHEMBL932540 1.00 LIPG (0.58) LIPGTLR8NR1H2NR1H3CYP1A2
SCHEMBL177297 1.00 LIPG (0.58) LIPGTLR8NR1H2NR1H3CYP1A2
SCHEMBL985061 1.00 LIPG (0.58) LIPGTLR8NR1H2NR1H3CYP1A2
SCHEMBL983151 1.00 LIPG (0.58) LIPGTLR8NR1H2NR1H3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122095059-A Contains high content of C9Lubricant composition of di-substituted diphenylamine antioxidant 2026-05-26 CN claimed
EP-4545621-A2 LUBRICANT COMPOSITIONS CONTAINING HIGH C9 DISUBSTITUTED DIPHENYLAMINE ANTIOXIDANT CONTENT Infineum International Limited (GB) 2025-04-30 EP claimed
CN-122095059-A Contains high content of C9Lubricant composition of di-substituted diphenylamine antioxidant 2026-05-26 CN disclosed
WO-2026087620-A1 LUBRICANT COMPOSITIONS CONTAINING HIGH C9 DISUBSTITUTED DIPHENYLAMINE ANTIOXIDANT CONTENT INFINEUM INTERNATIONAL LIMITED (GB) 2026-04-30 WO disclosed
EP-4731689-A1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE Covestro Deutschland AG (DE) 2026-04-29 EP disclosed
EP-4122972-B1 POLYETHER COMPOUND, IONIC COMPOSITION, AND MOLDED BODY ZEON CORP (JP) 2026-04-29 EP disclosed
US-20260109910-A1 Lubricant Compositions Containing High C9 Disubstituted Diphenylamine Antioxidant Content and Low Mono- and Tri-substituted Diphenylamine Antioxidant Content INFINEUM INTERNATTIONAL LTD (GB) 2026-04-23 US disclosed
US-12570798-B2 Polyether compound and gas separation membrane ZEON CORPORATION (JP) 2026-03-10 US disclosed
EP-4694606-A1 RADIO WAVE SHIELDING BODY AND ADHESIVE COMPOSITION Zeon Corporation (JP) 2026-02-11 EP disclosed
EP-4448605-B1 PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE COVESTRO DEUTSCHLAND AG (DE) 2025-11-19 EP disclosed
EP-4200351-B1 METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE COVESTRO DEUTSCHLAND AG (DE) 2025-11-19 EP disclosed
US-4364942-A ANTIDEPRESSANTS, INHIBITORS OF MONOAMINE OXIDASE JANSSEN PHARMACEUTICA N.V. (BE) 1982-12-21 US disclosed
US-4340738-A ENZYME INHIBITORS, ANTIDEPRESSANTS JANSSEN PHARMACEUTICA, N.V. (BE) 1982-07-20 US disclosed
US-4279761-A LUBRICANT ADDITIVE CIBA-GEIGY CORPORATION (US) 1981-07-21 US disclosed
US-4262004-A MONOAMINE OXIDASE INHIBITORS JANSSEN PHARMACEUTICA, N.V. (BE) 1981-04-14 US disclosed
US-4244827-A AS STABILIZING ADDITIVES FOR LUBRICANTS CIBA-GEIGY CORPORATION (US) 1981-01-13 US disclosed
EP-0021806-A1 2,3-Dihydro-imidazo (2,1-b) benzothiazole derivatives and pharmaceutical compositions containing them JANSSEN PHARMACEUTICA N.V. (BE) 1981-01-07 EP disclosed
EP-0021807-A1 3,4-Dihydro-2H-pyrimido (2,1-b) benzothiazoles and pharmaceutical compositions containing them JANSSEN PHARMACEUTICA N.V. (BE) 1981-01-07 EP disclosed
US-4080307-A AMMONIUM SALTS OF 1,3-OXA- OR 1,3-THIA-PHOSPHETANES CIBA-GEIGY AG (CH) 1978-03-21 US disclosed
US-4079012-A Synthetic ester oil compositions containing organic sulfonic acid ammonium salts as load-carrying agents BOSNIACK DAVID S 1978-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570798-B2 Polyether compound and gas separation membrane KCNE1, PARG, TRPA1 LIPG 1859/4885TLR8 357/4885NR1H2 4169/4885
US-20260109910-A1 Lubricant Compositions Containing High C9 Disubstituted Diphenylamine Antioxidant Content and Low Mono- and Tri-substituted Diphenylamine Antioxidant Content C9, SOD1, TDO2 LIPG 1520/4885TLR8 19/4885NR1H2 2767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.